Rating History for Akcea Therapeutics, Inc. (AKCA) by BMO Capital
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/1/2020 | Do Kim | Downgrade | Market Perform (Outperform) |
18.15 (26.00) |
11.38 (18.17) |
59.67% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
